GB0507548D0 - Compounds and methods for the prevention of the development of neutralising antibodies to a biologic - Google Patents

Compounds and methods for the prevention of the development of neutralising antibodies to a biologic

Info

Publication number
GB0507548D0
GB0507548D0 GBGB0507548.6A GB0507548A GB0507548D0 GB 0507548 D0 GB0507548 D0 GB 0507548D0 GB 0507548 A GB0507548 A GB 0507548A GB 0507548 D0 GB0507548 D0 GB 0507548D0
Authority
GB
United Kingdom
Prior art keywords
biologic
prevention
compounds
development
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0507548.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Original Assignee
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin filed Critical College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Priority to GBGB0507548.6A priority Critical patent/GB0507548D0/en
Publication of GB0507548D0 publication Critical patent/GB0507548D0/en
Priority to PCT/IE2006/000033 priority patent/WO2006109286A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0507548.6A 2005-04-14 2005-04-14 Compounds and methods for the prevention of the development of neutralising antibodies to a biologic Ceased GB0507548D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0507548.6A GB0507548D0 (en) 2005-04-14 2005-04-14 Compounds and methods for the prevention of the development of neutralising antibodies to a biologic
PCT/IE2006/000033 WO2006109286A1 (en) 2005-04-14 2006-04-18 Filamentous hemagglutinin for the prevention of the development of neutralising antibodies to a biologic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0507548.6A GB0507548D0 (en) 2005-04-14 2005-04-14 Compounds and methods for the prevention of the development of neutralising antibodies to a biologic

Publications (1)

Publication Number Publication Date
GB0507548D0 true GB0507548D0 (en) 2005-05-18

Family

ID=34611117

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0507548.6A Ceased GB0507548D0 (en) 2005-04-14 2005-04-14 Compounds and methods for the prevention of the development of neutralising antibodies to a biologic

Country Status (2)

Country Link
GB (1) GB0507548D0 (en)
WO (1) WO2006109286A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69113564T2 (en) * 1990-08-13 1996-05-30 American Cyanamid Co Bordetella pertussis fiber hemagglutinin as a carrier for conjugated vaccine.

Also Published As

Publication number Publication date
WO2006109286A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
GB0718972D0 (en) Compounds and methods of making the compounds
IL198612A0 (en) Human antibodies to human delta like ligand 4
EP2076614A4 (en) Synthetic antibodies
EP2097534A4 (en) Human antibodies that bind cd70 and uses thereof
ZA200900395B (en) Antibodies directed to +-Vß6 and uses thereof
IL189788A0 (en) Human monoclonal antibodies to cd70
SI1973950T1 (en) Anti-ephb4 antibodies and methods using the same
EP1869192A4 (en) Framework-shuffling of antibodies
IL197614A0 (en) Thiazole pyrazolopyrimidine compounds
GB0517487D0 (en) Antibodies
ZA200904657B (en) Human antibodies that bind CD70 and uses thereof
EP1757933A4 (en) Method for the determination of body odor
ZA200802641B (en) Human monoclonal antibodies to CD70
GB0525541D0 (en) Detection of antibodies
EP1984385A4 (en) Methods for the synthesis of dicarba bridges in organic compounds
GB0603728D0 (en) Closure
GB0521726D0 (en) Methods for the preparation of organic compounds
GB0521728D0 (en) Methods for the preparation of organic compounds
GB2432359B (en) Closure
EP1896047A4 (en) Anti-gfralpha3 antibodies
GB0505489D0 (en) Antibodies
GB0507548D0 (en) Compounds and methods for the prevention of the development of neutralising antibodies to a biologic
GB0616902D0 (en) Closure
EP1892301A4 (en) Method for evaluation of compound using rsk1
GB0512278D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)